Baycrest Heath Sciences' "My Virtual Dream," an innovative and interactive live performance experience at the intersection of science, art and music, is currently touring the installation with appearances in Amsterdam in May and more scheduled for Irvine, CA in October.
MaRS Innovation is working with the Baycrest team to commercialize the technology behind the demonstration, known as the virtual brain.
My Virtual Dream was featured in TechVibes on July 8 and in a PLOS blog published on August 14, 2015.
“The Virtual Dream tour ...
Fanny Sie, MaRS Innovation's head of imaging technologies, was quoted in Tanya Powley's article, "Printing whole organs remains a long way off," for the U.K.'s Financial Times on June 11, 2015, regarding the technology's potential to transform existing healthcare practices.
MI does wish to note that the article inaccurately attributes the PrintAlive device's development to MaRS Innovation; MI is working with the University of Toronto inventing team, led by Dr. Axel Gunther, to commercialize the device.
Here's a short excerpt:
Bioprinting could save pharmaceutical ...
Toronto-based commercial arm of BioDiaspora research program tracks global spread of infectious diseases in real-time; fourth MI company to reach Series A
TORONTO (Dec. 2, 2014) — BlueDot, a Toronto-based social benefit corporation founded by Dr. Kamran Khan, an infectious disease physician and scientist, tracks and predicts the global spread of infectious diseases.
Spun off from St. Michael’s Hospital in partnership with MaRS Innovation (and formerly known as BioDiaspora Inc.), BlueDot, has secured a Series A venture capital funding from Horizons Ventures. Funded ...
Fanny Sie, MaRS Innovation's head of imaging technologies and a manager in the Technology & Venture Development group, is speaking about bioprinting trends at two Toronto conferences this weekend.
Sie is MI's commercialization lead on the Bioprinter, a licensenable technology from the University of Toronto and Sunnybrook Health Sciences Centre.
Watch her interview on bioprinting with TVO's The Agenda, which aired in June 2013.
First up is Digifest, an international festival celebrating digital creativity, which runs from May 8 to 10 at the Corus ...
The Bioprinter project, a three-way initiative from MaRS Innovation, the University of Toronto and Sunnybrook Health Sciences Centre, was featured on Canada AM on January 29 during a segment with Dr. Marla Shapiro, the program's Health and Medical Expert.
The Bioprinter, whose commercial applications are being developed by MI's Fanny Sie, is a 3D printer than can print on organic material, including skin.
Click here to watch the full segment on CTV's Canada AM.
Shapiro visited Dr. Marc Jeschke and his team in his lab at Sunnybrook to ...
MI Project Manger Fanny Sie discusses Toronto’s impact on 3D printing landscape
In a December 4 article, part of a feature series on technology in Toronto, Yonge Street Media reporter Andrew Seale highlights the creative and innovative technological work surrounding the 3D printing and cyber security sectors in the city.
MaRS Innovation’s Fanny Sie is managing business development for the Bioprinter, a 3D printer using University of Toronto technology that’s capable of printing on organic material, including skin.
By printing on skin, the cost of treating burns ...
“It’s one thing to invent a machine that prints skin, but it’s a whole other challenge to bring what seems like the domain of mad science to mass production,” Matthew Braga wrote in "Looking for ways to get 'skin' in the game," published in the Financial Post on July 15.
The article focuses on MaRS Innovation's (MI) and the Innovations and Partnerships Office's (University of Toronto) joint efforts to commercialize the bio printer, a "prototype 3D printer that, instead of extruding layers ...
MI's Fanny Sie and Shotlst Co-founder Matt Ratto talk bioprinting, healthcare, civil rights and home manufacturing with Steve Paikin
Fanny Sie, project manager in physical sciences and medical devices with specialization in medical imaging, appeared on TVO’s The Agenda on June 5, 2013 to discuss 3D printing.
Click here to watch Fanny Sie on The Agenda.
Sie manages the Bioprinter technology, which was touched upon during the interview. The bioprinter was invented by Axel Guenther, a professor in the University of Toronto’s Department of Mechanical ...
MaRS Innovation's Fanny Sie, project manager in physical sciences and medical devices with specialization in medical imaging, is appearing on TVO's The Agenda with Steve Paikin at 8 pm on June 5, 2013 to discuss 3D printing and the technology's applications in healthcare and other aspects of human society.
Sie manages the Bioprinter technology, which was invented by Axel Guenther, a professor in the University of Toronto’s Department of Mechanical and Industrial Engineering, PhD student Lian Leng and a team of other researchers. ...